🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is an open-label, multicenter, Phase Ib, dose-escalation and cohort-ex...
Status
Completed
Location
UCLA
Start Date
2012-08-13
Trial ID
NCT01656642
Treatments Being Tested
This is an open-label, multicenter, extension study. Patients who are recei...
Status
Active Not Recruiting
Location
University of Colorado Cancer Center
Start Date
2019-02-28
Trial ID
NCT03768063
This is a prospective non-randomized national clinical phase 2 trial that a...
Status
Recruiting
Location
Turku University Hospital Cancer Centre
Start Date
2021-12-10
Trial ID
NCT05159245
Evaluation of the efficacy, safety and biologic effects of neo-adjuvant tre...
Status
Terminated
Location
Department of Dermatology & Skin Cancer University Hospital La Timone, Aix-Marseille University
Start Date
2015-01-22
Trial ID
NCT02303951
Treatments Being Tested
IMPRESS-Norway is a prospective, non-randomized clinical trial evaluating e...
Status
Recruiting
Location
Sykehuset Ålesund
Start Date
2021-04-01
Trial ID
NCT04817956
Treatments Being Tested
The purpose of this study is to determine wether cobimetinib + vemurafenib ...
Status
Completed
Location
CHU de Bordeaux
Start Date
2015-12
Trial ID
NCT02537600
Treatments Being Tested
SMMART-ACT is a feasibility pilot study to determine if testing samples fro...
Status
Withdrawn
Location
Multiple Locations
Start Date
2023-01-30
Trial ID
NCT05238831
Treatments Being Tested
This trial explores the immunologic effects of vemurafenib (BRAF inhibitor)...
Status
Withdrawn
Location
The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Start Date
2015-08
Trial ID
NCT02427893
Treatments Being Tested
Rationale: The combination of ipilimumab and nivolumab induces relatively ...
Status
Unknown
Location
The Netherlands Cancer Institute
Start Date
2017-01-27
Trial ID
NCT02968303
Treatments Being Tested
The purpose of this study is to evaluate the effectiveness of the combinati...
Status
Terminated
Location
Harriet Kluger
Start Date
2015-02
Trial ID
NCT02230306
Treatments Being Tested